imipramine has been researched along with pregabalin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bach, FW; Brøsen, K; Finnerup, NB; Holbech, JV; Jensen, TS; Sindrup, SH | 2 |
| Bach, FW; Demant, D; Finnerup, NB; Holbech, J; Jensen, TS; Sindrup, SH | 1 |
| Friedland, K; Koch, E; Müller, WE; Nöldner, M; Schuwald, A; Silani, G; Stockburger, C | 1 |
1 review(s) available for imipramine and pregabalin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for imipramine and pregabalin
| Article | Year |
|---|---|
Imipramine and pregabalin combination for painful polyneuropathy: a randomized controlled trial.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Analgesics; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Pain Measurement; Pregabalin; Treatment Outcome; Young Adult | 2015 |
The Impact of Serum Drug Concentration on the Efficacy of Imipramine, Pregabalin, and their Combination in Painful Polyneuropathy.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Aged, 80 and over; Analgesics; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Pain Measurement; Peripheral Nervous System Agents; Polyneuropathies; Pregabalin; Treatment Outcome | 2017 |
Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Carbamazepine; Diabetic Neuropathies; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Oxcarbazepine; Polyneuropathies; Pregabalin; Retrospective Studies; Time Factors; Venlafaxine Hydrochloride | 2017 |
2 other study(ies) available for imipramine and pregabalin
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Neurotrophic Properties of Silexan, an Essential Oil from the Flowers of Lavender-Preclinical Evidence for Antidepressant-Like Properties.
Topics: Animals; Antidepressive Agents; Cell Culture Techniques; CREB-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Imipramine; Lavandula; Oils, Volatile; Plant Oils; Pregabalin; Rats; Rats, Sprague-Dawley | 2021 |